NPM1 Gene Fragment Analysis Test - $226 USD | Comprehensive Genetic Testing in USA
Microarray 60K POC Test - Products of Conception Analysis | $338 USD | USA Genetic Testing Microarray 60K POC Original price was: $450.Current price is: $338.
Pancreatic Mutation Panel Genetic Test - $712 USD | Comprehensive Hereditary Pancreatic Cancer Screening | Available Across USA Pancreatic Mutation Panel Original price was: $950.Current price is: $712.
Sale!

NPM1 Gene Fragment Analysis

Original price was: $300.Current price is: $226.

-25%

The NPM1 Gene Fragment Analysis is a specialized genetic test that detects mutations in the Nucleophosmin 1 gene, which plays a critical role in acute myeloid leukemia (AML) diagnosis and prognosis. This advanced molecular analysis helps identify specific genetic abnormalities that influence treatment decisions and patient outcomes. The test is particularly valuable for patients with suspected or confirmed AML, providing crucial information about disease classification and therapeutic options. With a turnaround time of 7-8 days and requiring only bone marrow or peripheral blood samples, this test offers comprehensive genetic insights. At just $226 USD, this essential diagnostic tool helps guide personalized treatment strategies and monitor disease progression effectively.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

NPM1 Gene Fragment Analysis

Comprehensive Genetic Testing for Acute Myeloid Leukemia

The NPM1 Gene Fragment Analysis represents a cutting-edge molecular diagnostic approach that plays a pivotal role in modern hematological medicine. This sophisticated genetic test specifically targets the Nucleophosmin 1 gene, which has emerged as a crucial biomarker in the diagnosis and management of acute myeloid leukemia (AML). By detecting specific mutations in the NPM1 gene, healthcare providers can gain valuable insights into disease classification, prognosis, and treatment planning.

What Does the NPM1 Gene Fragment Analysis Detect?

This advanced genetic test specifically identifies mutations in the NPM1 gene, particularly focusing on:

  • Frame-shift mutations in exon 12 of the NPM1 gene
  • Specific insertion mutations that alter nuclear localization
  • Genetic abnormalities associated with nucleocytoplasmic shuttling
  • Mutations that result in aberrant cytoplasmic localization of NPM1 protein

The test utilizes fragment analysis methodology, which provides high sensitivity and specificity in detecting these clinically significant genetic alterations. This approach ensures accurate identification of NPM1 mutations that are present in approximately 30-35% of adult AML cases.

Who Should Consider NPM1 Gene Fragment Analysis?

This genetic test is particularly recommended for individuals experiencing:

  • Newly diagnosed acute myeloid leukemia (AML)
  • Unexplained cytopenias or abnormal blood cell counts
  • Suspected hematological malignancies
  • Patients requiring comprehensive genetic profiling for AML classification
  • Individuals with family history of hematological disorders
  • Patients undergoing treatment monitoring for AML

Clinical Benefits of NPM1 Testing

Undergoing NPM1 Gene Fragment Analysis provides numerous clinical advantages:

  • Accurate Disease Classification: Helps classify AML into specific molecular subtypes
  • Prognostic Information: NPM1 mutations are generally associated with favorable outcomes in AML
  • Treatment Guidance: Influences chemotherapy selection and intensity decisions
  • Minimal Residual Disease Monitoring: Enables tracking of treatment response
  • Personalized Medicine Approach: Supports tailored treatment strategies
  • Early Detection Capabilities: Identifies genetic markers before clinical symptoms manifest

Understanding Your Test Results

Your NPM1 Gene Fragment Analysis results will be interpreted by our expert genetic counselors and hematologists:

  • Positive Result: Indicates presence of NPM1 mutation, typically associated with better prognosis in AML without FLT3-ITD mutation
  • Negative Result: No NPM1 mutation detected, which may influence alternative treatment approaches
  • Variant of Uncertain Significance: Rare genetic changes requiring additional clinical correlation
  • Technical Limitations: Results should be interpreted in clinical context with other diagnostic findings

All results include comprehensive interpretation and recommendations from our specialized medical team to ensure you understand the implications for your health management.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $226
Regular Price $300

Convenient Testing Locations Across USA

GGC DNA maintains comprehensive testing facilities in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and Charlotte. Our nationwide network ensures accessible genetic testing services for patients throughout the United States.

Book Your NPM1 Gene Fragment Analysis Today

Take the first step toward comprehensive genetic understanding and personalized medical care. Our experienced genetic counselors and hematology specialists are ready to guide you through the testing process and help interpret your results within the clinical context of your health situation.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or discuss any questions about the NPM1 Gene Fragment Analysis test.

With a rapid 7-8 day turnaround time and requiring only a simple bone marrow or peripheral blood sample collected in an EDTA Vacutainer, this test provides crucial genetic information that can significantly impact your treatment journey and long-term health outcomes.

SKU: 6a13382a520e Category:

Related products